| Relationship Between Dynamic MRI Findings and the Prognostic Factors of Breast Cancer | Lütfi DOĞAN, Hale AYDIN, Bahar GÜNER, Mehmet Ali GÜLÇELİK, Almıla COŞKUN BİLGE, Işıl ESEN BOSTANCI, Bilgin ARIBAŞ, Zarife Melda BULUT | 128–140 |
| The Expression of HBME1, PAX8, CD56 and CITED1 in Benign Lesions, Benign and Malignant Tumors of Thyroid | Gamze ERKILINÇ, Sezer KULAÇOĞLU | 141–151 |
| Consolidation with Autologous Stem Cell Transplantation in Patients with Primary Central Nervous System Lymphoma | Semih BAŞÇI, Fevzi ALTUNTAŞ, Bahar UNCU UNLU, Mehmet Sinan DAL, Tuğçe Nur YÜCEL, Mehmet BAKIRTAŞ, Derya ŞAHİN, Tahir DARÇIN, Jale YILDIZ, Nuran Ahu BAYSAL, Dicle İSKENDER, Merih KIZIL ÇAKAR | 152–158 |
| Evaluation of Bone Mineral Densitometry Measurements in Patients with BCR/ABL-Negative Chronic Myeloproliferative Neoplasm | Sema AKINCI, Aysun ŞENTÜRK YIKILMAZ, Şule Mine BAKANAY, İmdat DİLEK, Selin KÜÇÜKYURT KAYA | 159–165 |
| Prognostic Value of Lymphovascular and Perineural Invasion in Colon Cancer | Afig GOJAYEV, Ali Ekrem ÜNAL, Cemil YÜKSEL, Serdar ÇULCU, Salim DEMİRCİ | 166–174 |
| Juxtacortical Chondrosarcoma: Analysis of 52 Cases | Recep ÖZTÜRK, Emin Kürşat BULUT, Mahmut Nedim AYTEKİN, Kamil AMER | 175–180 |
| The Effects of Laxative Use on Rectum Volume and Doses During Radiotherapy in Patients With Prostate Cancer | Evrim DUMAN, Neslihan ATABEK, Yılmaz BİLEK | 181–188 |
| Expression of CD10, BCL-6 and MUM-1 Markers and Their Effects on Prognosis in Diffuse Large B Cell Lymphoma | Nalan AKYÜREK, Ahmet YOZGAT, Benan KASAPOĞLU, Aytuğ ÜNER | 189–197 |
| Kinesiophobia in Breast Cancer Survivors and its Relationship with Quality of Life, Comorbidity and Other Clinical Parameters | Veli SUNAR, İsmihan SUNAR | 198–205 |
| Disease and Clinical Characteristics of Patients with Chronic Myeloproliferative Neoplasms: 11-year Single Center Experience | Hacer Berna AFACAN ÖZTÜRK, Abdulkerim YILDIZ, Murat ALBAYRAK, Senem MERAL, Pınar AKYOL, Merih Reis ARAS, Buğra SAĞLAM, Mesut TİĞLİOĞLU, Fatma YILMAZ | 206–216 |
| Predictive Value of Complete Blood Count Inflammatory Parameters for Epithelial Ovarian Cancers in Women During Reproductive Period |